Vivo Opportunity Fund Holdings, L.P. - 30 Jun 2025 SCHEDULE 13G/A Report for Cidara Therapeutics, Inc. Common Stock, $0.0001 par value (CDTX)

Filing Manager
Vivo Opportunity Fund Holdings, L.P.
Reporting Manager
Vivo Opportunity Fund Holdings, L.P.
Security
Cidara Therapeutics, Inc. Common Stock, $0.0001 par value
Symbol
CDTX
Shares outstanding
25,560,783 shares
Disclosed Ownership
1,175,796 shares
Ownership
4.6%
Form type
SCHEDULE 13G/A
Filing time
12 Aug 2025, 20:50:55 UTC
Date of event
30 Jun 2025
Previous filing
15 May 2025
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Vivo Opportunity Fund Holdings, L.P. 4.6% 1,175,796 1,175,796 0 /s/ Kevin Dai Kevin Dai/Managing Member
Vivo Opportunity, LLC 4.6% 1,175,796 1,175,796 0 /s/ Kevin Dai Kevin Dai/Managing Member
Vivo Opportunity Cayman Fund, L.P. 0.5% 135,629 135,629 0 /s/ Kevin Dai Kevin Dai/Managing Member
Vivo Opportunity Cayman, LLC 0.5% 135,629 135,629 0 /s/ Kevin Dai Kevin Dai/Managing Member